Publication | Closed Access
CuCo<sub>2</sub>O<sub>4</sub> Nanoflowers with Multiple Enzyme Activities for Treating Bacterium-Infected Wounds via Cuproptosis-like Death
226
Citations
32
References
2024
Year
Nanozyme-driven catalytic therapy provides a promising treatment strategy for bacterial biofilm-infected wounds. However, the single functionality and limited catalytic efficiency of nanozyme-based materials often restrict the effectiveness of wound infection treatment. In this study, CuCo<sub>2</sub>O<sub>4</sub> nanoflowers with multiple enzymatic activities were prepared for antibacterial/antibiofilm treatment by cuproptosis-like death. CuCo<sub>2</sub>O<sub>4</sub> exhibited peroxidase-like (POD-like) and oxidase-like (OXD-like) dual enzyme activities that generated large amounts of •OH and O<sub>2</sub><sup>•-</sup>. Moreover, the glutathione peroxidase-like (GSH-Px-like) activity of CuCo<sub>2</sub>O<sub>4</sub> was able to reduce the overexpression of GSH in the wound microenvironment, enhancing the therapeutic effects of reactive oxygen species (ROS). The morphology of CuCo<sub>2</sub>O<sub>4</sub> was modified using a hydrothermal method with PEG4000 as the solvent, resulting in the exposure of more active center sites and a significant improvement in enzyme catalytic activity. The in vitro results demonstrated the pronounced disruption effect of CuCo<sub>2</sub>O<sub>4</sub> on biofilms formed by bacteria. In vivo, CuCo<sub>2</sub>O<sub>4</sub> significantly promoted angiogenesis, collagen deposition, and cell proliferation. Transcriptome sequencing revealed that elevated ROS levels in bacteria led to cell membrane damage and metabolic disruption. In addition, Cu<sup>2+</sup> overload in bacteria induces lipid peroxidation accumulation and disrupts the respiratory chain and tricarboxylic acid (TCA) cycle, ultimately leading to bacterial cuproptosis-like death. This therapeutic strategy, which combines the synergistic effects of multiple enzyme-like activities with cuproptosis-like death, provides an approach for treating biofilm infections.
| Year | Citations | |
|---|---|---|
Page 1
Page 1